Alström syndrome (AS) is characterised by metabolic deficits, retinal dystrophy, sensorineural hearing loss, dilated cardiomyopathy and multi-organ fibrosis. Elucidating the function of the mutated gene, ALMS1, is critical for the development of specific treatments and may uncover pathways relevant to a range of other disorders including common forms of obesity and type 2 diabetes. Interest in ALMS1 is heightened by the recent discovery of its involvement in neonatal cardiomyocyte cell cycle arrest, a process with potential relevance to regenerative medicine. ALMS1 encodes a ~ 0.5 megadalton protein that localises to the base of centrioles. Some studies have suggested a role for this protein in maintaining centriole-nucleated sensory organelles termed primary cilia, and AS is now considered to belong to the growing class of human genetic disorders linked to ciliary dysfunction (ciliopathies). However, mechanistic details are lacking, and recent studies have implicated ALMS1 in several processes including endosomal trafficking, actin organisation, maintenance of centrosome cohesion and transcription. In line with a more complex picture, multiple isoforms of the protein likely exist and non-centrosomal sites of localisation have been reported. This review outlines the evidence for both ciliary and extra-ciliary functions of ALMS1.
Alström syndrome (AS) is a rare, recessively inherited disorder that affects numerous organ systems [1, 2]. Cardinal features include childhood obesity, insulin resistance, cone-rod retinal dystrophy and sensorineural hearing loss (SNHL). Type 2 diabetes mellitus and hypertriglyceridemia typically develop in childhood or adolescence [2,3,4]. Dilated cardiomyopathy (DCM) may arise in infancy, then often resolve or at least abate within 3 years. However, it may recur, or manifest for the first time, in adolescence or adulthood [2, 3, 4, 7]. Other common features include hepatic, renal and pulmonary dysfunction, chronic otitis media in childhood, abnormal spinal curvature (scoliosis, kyphosis or lordosis) arising in adolescence, short stature in adulthood, gastrointestinal disturbances and neurological disturbances such as absence seizures [3,4,5,6]. Fibrosis of multiple organs is a common finding .
Understanding the molecular basis of AS is critical for the development of specific therapies. It may also provide new insights into the molecular pathways that go awry in common forms of conditions such as obesity and diabetes, which represent major public health concerns [8, 9].
The prevalence of AS is estimated at 1–9 cases per million individuals, with approximately 950 reported cases . It is caused by mutations in ALMS1, a widely expressed 23-exon gene located on chromosome 2p13 [11, 12]. Over 200 different AS-causing variants have been identified, of which the vast majority are nonsense or frameshift mutations [13, 14]. Almost half occur in exon 8 , commensurate with the large size of this exon (6.1 kb, or 49% of the coding sequence). There is little evidence of genotype-phenotype correlation, suggesting that the phenotype is modified by unknown genetic and/or environmental factors .
Intriguingly, biallelic mutations in ALMS1 also cause mitogenic cardiomyopathy, an ultra-rare form of DCM characterised by delayed cell cycle arrest of neonatal cardiomyocytes [15, 16]. This condition is fatal in the first months of life, before other clinical features of AS normally manifest. The few mutations reported so far resemble those commonly found in AS, being located in the three largest exons (exons 8, 10 and 16) and predicted to cause premature termination of translation. Alms1 also appears to be required for timely postnatal cell cycle arrest of cardiomyocytes in mice . Thus, mitogenic cardiomyopathy is most likely an extreme form of the infantile DCM often observed in AS [15, 16]. Mechanisms regulating cardiomyocyte cell cycle arrest are of great interest partly because reversing this process could provide a way to stimulate cardiac regeneration after injury .
The ALMS1 protein is a component of the centrosome [18, 19], a microtubule (MT)-nucleating organelle comprising two centrioles (termed mother and daughter) and a dynamic assembly of proteins termed pericentriolar material (PCM). Centrioles are evolutionarily conserved cylindrical structures composed of nine triplet MTs, approximately 500 nm in length . Notably, ALMS1 localises specifically to the base, or proximal end, of these structures  (Figs. 1 and 2).
Centrioles duplicate once per cell cycle, beginning at the G1/S transition, and the two resulting centrosomes go on to form the poles of the mitotic spindle  (Fig. 2). In interphase, and in some terminally differentiated cell types, the centrosome anchors a radial array of MTs that forms the basis of an intracellular transport system and influences cell shape, polarity and motility [22, 23]. In addition to its classical roles in MT organisation, the centrosome has recently been reported to nucleate actin filaments, facilitate endocytic recycling and direct multiple events at the immunological synapse [24,25,26]. It also serves as a hub for components of the cell cycle regulatory machinery and proteasome, and has been linked to the DNA damage response (DDR) [27,28,29]. Of note, mutations in genes encoding the centrosomal proteins pericentrin (PCNT) and POC1A are associated with severe insulin resistance [30, 31], while disruption of the centrosomal protein CEP19 causes morbid obesity . Mutations in several centriole biogenesis genes cause forms of microcephaly .
Centrioles are vital for the assembly of cilia, hair-like projections that are either motile, as in multiciliated epithelial cells (MCCs), or non-motile. Most quiescent/terminally differentiated (G0) human cells possess a single non-motile (primary) cilium, nucleated by the mother centriole of the centrosome (termed a basal body when ciliated) (Fig. 2). The core, or axoneme, of primary cilia consists of nine doublet MTs and is enclosed in a lipid bilayer that is continuous with the plasma membrane . In many cell types, the periciliary membrane forms an invagination called the ciliary pocket, which is a site of endocytosis and possibly a docking site for Golgi-derived vesicles . Protein synthesis does not occur within cilia and therefore all components must be transported from the cell body. A continuously running MT motor-based system termed intraflagellar transport (IFT) shuttles cargo molecules from the base to the tip of the cilium and vice versa . Importantly, the protein and lipid composition of the ciliary compartment is controlled by a ‘gate’ at the ciliary base, part of which is the transition zone (TZ), defined by Y-shaped links extending from the axoneme to the ciliary membrane  (Fig. 2).
Notably, the light-sensing outer segment (OS) of vertebrate photoreceptors is a highly specialised form of primary cilium . The OS is packed with stacks of opsin-containing membrane disks that are shed from the distal end and renewed at the base. This requires high-volume trafficking of OS components from their site of synthesis in the inner segment (IS) through a narrow structure called the connecting cilium (CC), which resembles an extended TZ and is nucleated by a basal body in the distal IS [35, 36]. Another specialised type of primary cilium is present on hair cells in the developing organ of Corti. This ‘kinocilium’ and/or its basal body help to choreograph the formation of mechanically sensitive bundles of stereocilia (actin-based structures unrelated to primary cilia), which are central to hearing, on the apical cell surface [37, 38].
Interest in primary cilia has widened dramatically in recent years due to accumulating evidence of their importance for normal development, tissue homeostasis and energy balance [39,40,41]. They appear to sense and process a variety of molecular cues, helping cells throughout the body to respond to changes in the extracellular environment. For example, vertebrate cells require primary cilia to respond to Hedgehog (Hh) family ligands, which play crucial roles in development and stem cell maintenance . The signalling process involves dynamic localisation of effector transcription factors and other pathway components to the ciliary compartment . In growth-arrested cells, platelet-derived growth factor receptor α (PDGFRα) and insulin-like growth factor 1 receptor (IGF-1R) localise to the ciliary membrane, where they trigger downstream signalling upon ligand-binding, leading to responses such as cell cycle re-entry [43,44,45]. Primary cilia are involved in numerous other signalling pathways, including the Wnt/PCP (planar cell polarity), Notch and TGF-β pathways, and may thus serve to integrate multiple signals to ensure an appropriate cellular response [39, 46,47,48]. The primary cilia of some cells, such as renal tubule epithelial cells, are thought to sense fluid flow via mechanosensitive calcium channel complexes within the ciliary membrane . However, this aspect of cilia function has been questioned by recent data [49, 50].
While cilia-mediated signalling can influence the cell cycle, ciliation status is in turn controlled by cell cycle kinases . Moreover, ciliogenesis and/or cilium length are modulated by inputs from other processes such as autophagy, actin cytoskeleton organisation and ciliary signalling itself .
Dozens of genetic disorders have now been linked to cilia dysfunction . Clinical features common to several of these so-called ciliopathies include renal cysts, brain abnormalities, polydactyly and retinal dystrophy [53,54,55]. The products of many of the mutated genes have been shown to work together in complexes or functional modules, helping to explain both the genetic heterogeneity of several ciliopathies and the many examples of genetic overlap [52,53,54]. ALMS1 loss-of-function has been linked to defects in primary cilium formation, positioning and maintenance, leading to AS being classified as a ciliopathy [56,57,58,59]. However, the precise role of the ALMS1 protein remains uncertain and no clear links have been established with other ciliopathy proteins.
The phenotype of AS resembles that of the genetically heterogeneous ciliopathy Bardet-Biedl syndrome (BBS), which includes childhood obesity, retinal dystrophy, SNHL and susceptibility to type 2 diabetes [9, 60]. The functions of many BBS proteins converge at an evolutionarily conserved protein complex termed the BBSome [61, 62], to which various functions have been ascribed including promotion of ciliary membrane biogenesis, trafficking of ciliary membrane proteins and regulation of IFT particle assembly [61, 63,64,65]. BBS proteins also appear to have extraciliary functions, for example mediating trafficking of the insulin and leptin receptors to the plasma membrane [66, 67].
AS also bears similarity to the phenotype of mice with a mutation in the Tub gene, characterised by obesity, insulin resistance, retinal degeneration and SNHL [68, 69]. The Tubby protein is implicated in trafficking G protein-coupled receptors (GPCRs) and transient receptor potential (TRP) channels to neuronal cilia [70, 71], and may also act as a transcription factor .
While ALMS1 is known to localise to centrioles/basal bodies [19, 21, 56, 57], localisation to non-centrosomal sites has also been reported and recent studies have implicated the protein in several cellular processes including endosomal trafficking, actin organisation and transcription [73,74,75,76,77]. On broader scales, ALMS1 has been implicated in neuronal migration, maintenance of cellular quiescence, adipogenesis, spermatogenesis, maintenance of pancreatic β cell mass, adaptive thermogenesis and, as noted above, cell cycle arrest of cardiomyocytes [15, 16, 57, 78,79,80,81,82].
This review focuses on the quest to understand AS at the molecular and cell biological levels. In addition to results from mouse model- and cell-based functional studies, recent insights into ALMS1 gene regulation and the interaction network of the encoded protein are highlighted.
The ALMS1 protein
ALMS1 is a large (> 4000 residue) protein that lacks known catalytic domains [11, 12]. It has several sequence features of unknown function, including a large tandem repeat domain (TRD), three short predicted coiled-coil domains and a stretch of ~ 130 residues at the C-terminus dubbed the ALMS motif (Fig. 3). The ALMS motif is the only region that shares obvious sequence similarity with other human proteins. It was defined on the basis of similarity to mammalian orthologues of C10orf90/FATS (fragile site-associated tumour suppressor) , reportedly an E2-independent ubiquitin ligase which stabilises p53 in response to DNA damage  and may localise to the centrosome and actin cytoskeleton . A more divergent ALMS motif was subsequently identified at the C-terminus of CEP295/KIAA1731 , a large protein implicated in centriole assembly and maintenance [21, 84,85,86,87]. Notably, the CEP295 ALMS motif appears to bind MTs . Deletion analysis of ALMS1 suggests that its ALMS motif may contribute to centrosome-targeting . However, the motif is not essential for centrosomal localisation of either ALMS1 or CEP295 [21, 84, 85].
Orthologues of ALMS1 are readily detectable in chordates, although most of the N-terminal half of the protein, which mainly comprises the TRD, appears to be specific to mammals [21; unpublished observation]. The proteomes of many ciliated eukaryotes, including unicellular organisms such as Tetrahymena and Paramecium, contain predicted proteins with C-terminal ALMS motif-like sequences, suggesting that the motif has an ancient, conserved function relating to centrioles or cilia .
Experimentally defined sites of post-translational modification in ALMS1 include a cluster of ubiquitination sites around the third predicted coiled-coil domain  and a DNA damage-regulated phosphorylation site (S2781)  (data accessed via PhosphoSitePlus ). Regarding the latter, it is notable that a genome-wide RNAi screen identified ALMS1 as one of ~ 800 genes required for resistance to ionising radiation in U2OS cells . Other ciliopathy-associated proteins have been linked to DDR signalling  but the potential role of ALMS1 in this process remains to be investigated.
Regulation of ALMS1 gene expression
ALMS1 is widely expressed [11, 12, 19, 93] but its level of expression is context-dependent. For example, Alms1 mRNA declines during in vitro differentiation of 3T3-L1 preadipocytes [79, 94], possibly related to the observation that mature adipocytes lack primary cilia . Conversely, it increases during terminal differentiation of neonatal mouse cardiomyocytes  and in cell culture conditions that promote cell cycle exit and primary cilium formation (i.e. serum-starvation or confluency) [57, 96, 97]. It also increases during differentiation of MCCs in vitro [98, 99], possibly reflecting a requirement for the protein at the hundreds of basal bodies assembled in these cells.
The ALMS1 promoter contains an evolutionarily conserved consensus binding site for ciliogenic RFX (regulatory factor X) transcription factors, three of which (RFX1, RFX2 and RFX3) have been implicated in activating ALMS1 transcription in response to serum-starvation . Involvement of RFX proteins is supported by ChIP-Seq data from other studies, for example for murine Rfx1 and Rfx3 in neural progenitors and Min6 insulinoma cells, respectively [100, 101] (data accessed via the Cistrome Data Browser ). Vertebrate RFX2 and RFX3 have well-established roles in regulating ciliary genes in various tissues , while RFX1 has recently been reported to stimulate transcription of key ciliogenic genes downstream of leptin in hypothalamic neurons and to regulate other ciliary genes [104, 105]. However, it should be noted that RFX1 and RFX3 also regulate non-ciliary genes [100, 103, 106].
In Xenopus differentiating MCCs, Alms1 transcription appears to be upregulated by a protein complex containing Multicilin and the DNA-binding transcription factor E2f4 . Many of the genes targeted by this complex in MCCs encode factors that, in proliferating cells, are known to be involved in centriole biogenesis .
Protein-protein interactions and proximity interactions
Numerous candidate ALMS1-interacting proteins have been reported. Members of the α-actinin family of actin-binding proteins were identified in yeast two-hybrid (Y2H) screens using the C-terminal region of murine Alms1 as bait, and co-immunoprecipitation data supported an interaction with α-actinin-4 (Actn4) in mouse kidney . ACTN4 and another protein identified in the same Y2H screen (myosin Vb) are components of the cytoskeleton-associated recycling or transport (CART) complex, involved in endosomal recycling . Myo5b also interacts with a key regulator of ‘slow’ recycling pathways, Rab11 , and shares the ability of Myo5a to interact with the ciliopathy protein RPGRIP1L . α-Actinins and another protein identified in the same Y2H screen, Rab-interacting lysosomal protein-like 1 (Rilpl1), have also been implicated in ciliary roles [110, 111].
An ongoing human interactome study based on affinity purification coupled with mass spectrometry (AP-MS) [112, 113] has identified 18 potential ALMS1 interactors including the BBSome subunit BBS7; AVIL (advillin), which severs actin filaments and influences ciliogenesis ; RABL2A, the mouse orthologue of which binds CEP19 and IFT proteins [115,116,117]; cell division cycle 16 (CDC16), a component of the anaphase-promoting complex; dynamin 3 (DNM3), involved in membrane fission ; TFDP3, a dimerization partner of E2F transcription factors ; and dysbindin/dystrobrevin binding protein 1 (DTNBP1), a subunit of the BLOC-1 complex that is involved in recycling endosome formation and GPCR trafficking in the lysosomal pathway, and is required for trafficking of polycystin-2 to cilia [120,121,122]. Another global AP-MS study identified an interaction with VCIP135/valosin-containing protein-interacting protein 1 (VCPIP1) , a deubiquitinating enzyme which functions in membrane fusion [124, 125].
Other AP-MS studies have identified ALMS1 as a possible binding partner of the RNA polymerase II (RNAPII) subunit RPB1 ; the serine-arginine protein kinase SRPK2 ; GPCR-associated sorting protein 2 (GPRASP2), implicated in ciliary translocation of Smoothened, a key component of the Hh signalling pathway [127, 128]; and CEP192, a protein involved in centrosome biogenesis . Consistent with the latter finding, ALMS1 was labelled by a CEP192-biotin ligase fusion (bait) in a proximity-dependent biotinylation (BioID) study . However, because ALMS1 was labelled by baits representing several centriole duplication factors (PLK4, CEP152, CPAP, CEP63 and KIAA0753), it was suggested that at least in some cases this may reflect a dispersed localisation or high mobility within the centrosome . In a BioID study focusing on centrioles, cilia and centriolar satellites, centriole assembly factors including CEP152, CPAP, CEP135 and SASS6 were among 11 baits producing high confidence proximity interactions with ALMS1 . Collectively, these data may indicate that ALMS1 is present at the proximal ends of nascent procentrioles. However, the timing of ALMS1’s recruitment to newly forming centrioles is unknown, and it remains to be determined if the BioID results reflect physical interactions.
BioID has also identified ALMS1 as a potential interactor/substrate of the E3 ubiquitin ligase SCFβ-TrCP1 , and of separase , a protease that mediates separation of sister chromatids, and of newborn centrioles from their parents, in mitosis . Another recent BioID study suggests links to proteins involved in the Hippo signalling pathway (LATS2 and AMOT; ). An updated list of reported physical and proximity interactions is available online at thebiogrid.org .
The notion that ALMS1 has a ciliary role probably first arose when BBS was linked to basal body/primary cilium dysfunction . As outlined below, supporting evidence has emerged from analyses of ALMS1-deficient mice and ALMS1-depleted cultured cells, although not to date from analyses of AS patient fibroblasts.
Mice with a gene trap in intron 13 (Alms1GT/GT mice) appear to form cilia normally, based on electron microscopy analysis of renal collecting ducts, photoreceptors and airway epithelium . However, within photoreceptors a fraction of rhodopsin mislocalises to the outer nuclear layer (ONL) and vesicles accumulate in the IS, suggesting a defect in the tethering, docking or fusion of rhodopsin carrier vesicles at the base of the connecting cilium  (Fig. 4a). Photoreceptor degeneration is evident by the age of 24 weeks in these mice.
In the developing organ of Corti in Alms1GT/GT mice, the kinocilium of outer hair cells (OHC) is often mis-positioned and some stereociliary bundles display defects in shape and orientation  (Fig. 4b). These abnormalities, which resemble those seen in mouse models of BBS , implicate ALMS1 in cilium-dependent PCP signalling . The kinocilium appears to be required for normal bundle shape and orientation in individual OHCs, but not for polarisation of core PCP proteins . Only ~ 20% of OHC bundles are affected in Alms1GT/GT mice, suggesting that Alms1 dysfunction renders this cell type susceptible to a stochastic event during development . Progressive loss of OHCs also occurs and appears to be the main cause of hearing loss in these mice, although it is unclear if this is directly related to the observed bundle abnormalities .
Mice with an N-ethyl-N-nitrosourea (ENU)-induced nonsense mutation in exon 10 (Alms1L2131X/L2131X mice) exhibit loss of renal primary cilia by 6 months of age . Notably, only certain proximal tubules are affected, suggesting that an additional, somatic, event may be required . Cilia-loss correlates with increased proliferation and apoptosis of tubule epithelial cells  but whether it triggers these changes remains unknown (Fig. 4c). Rhodopsin mislocalises to the ONL in some photoreceptors of Alms1L2131X/L2131X mice, similar to Alms1GT/GT mice. Also of note, sperm flagella, which are structurally similar to cilia, are reduced in number and length compared to wild-type .
Mice with a truncating mutation in exon 8 (Alms1foz/foz mice) have also been reported to exhibit age-dependent loss of primary cilia, in this case on hypothalamic neurons . The loss begins between 5 days and 3 weeks of age, based on staining for AC3 (adenylate cyclase type 3), and seems to occur rapidly because the remaining cilia are not significantly shorter than those of control mice (Fig. 4d). Loss of cilia was supported by staining for three additional ciliary proteins (Sstr3, Mchr1 and Arl13b). Because the markers used are not core structural components of cilia, it is formally possible that their trafficking to cilia is blocked in subsets of Alms1foz/foz neurons. However, on the reasonable assumption that cilia are lost, the detection of Sstr3 and Mhcr1 in remaining cilia  is notable because ciliary localisation of these GPCRs is abrogated in Bbs and tubby mutant mice [71, 139].
Hypothalamic neuronal primary cilia are implicated in regulating satiety responses (via factors including Mchr1 and AC3) [139,140,141] and Alms1foz/foz mice are reportedly hyperphagic before becoming obese . Thus, resorption or degeneration of these cilia may contribute to the development of obesity in these mice . Although Alms1GT/GT and Alms1L2131X/L2131X mice also become obese [57, 93], preceding hyperphagia has not been documented and it is not known if loss of hypothalamic primary cilia occurs. Another notable feature of Alms1foz/foz mice is the degeneration of germ cells during spermatogenesis, particularly at the round-to-elongating stage during which flagella assembly occurs, although the assembly process is completed in some cells .
In summary, the initial formation of primary cilia appears normal in all three mouse models reported to date, consistent with their lack of obvious developmental phenotypes. However, age-dependent loss of primary cilia has been observed in Alms1L2131X/L2131X and Alms1foz/foz mice. Cilia-related deficits in a third model (Alms1GT/GT mice) include mislocalisation of rhodopsin and mispositioning of OHC kinocilia. Whether differences in the occurrence/timing of cilia-loss seen in these studies reflect the nature of the mutations, the focus on different cell types, or other factors, remains uncertain.
AS patient fibroblasts and ALMS1 siRNA-treated cells
The formation of primary cilia seems to be unaffected in AS patient fibroblasts in vitro [19, 76, 142]. Hh and PDGFA signalling, both of which act through the cilium, also appear to be normal . In stark contrast, transient RNAi-mediated depletion of ALMS1 has been reported to cause severe defects in ciliary structure. Ball-like staining of the ciliary axoneme marker acetylated tubulin was apparent in Alms1-depleted mouse inner medullary collecting duct (IMCD3) cells, using two different siRNAs . These malformed cilia were also functionally defective, based on measurement of intracellular calcium in response to fluid flow. A cDNA construct encoding the N-terminal 40% of Alms1 was reported to rescue cilium formation, although the effect was not quantified and the subcellular localisation of this N-terminal fragment was not reported . Knockdown of ALMS1 in human telomerase-immortalised retinal pigmented epithelium (hTERT-RPE1) cells has similarly been reported to result in the appearance of morphologically abnormal, stunted cilia , although whether the two siRNAs tested produced exactly the same effect is unclear.
Notably, Alms1 immunofluorescence is clearly visible at centrosomes in Alms1L2131X/L2131X and Alms1GT/GT mice, but not Alms1-depleted IMCD3 cells, using an N-terminal antibody [56, 57]. Moreover, Alms1 siRNA treatment has been reported to inhibit ciliogenesis in Alms1L2131X/L2131X embryonic fibroblasts . These findings suggest that RNAi suppresses ALMS1 expression more comprehensively than truncating mutations, at least in murine cells, offering a possible explanation for the striking effects on cilium morphology . If this is the case, then true null mutations in ALMS1 would likely disrupt ciliogenesis (assuming lack of adaptive compensation), leading to severe developmental defects and possibly embryonic lethality.
On the other hand, it could be argued that additional data are needed to confirm that the catastrophic ciliary defects seen in siRNA-treated cells are due to depletion of ALMS1. It is notable that Alms1 immunostaining was not detected in Alms1foz/foz neurons , nor in fibroblasts from 14 out of 16 AS patients with biallelic nonsense/frameshift mutations , implying the absence of residual protein function. Nevertheless, expression of ALMS1 isoforms lacking the antibody epitopes used for detection cannot be excluded in these cases.
Maintenance of centrosome cohesion and composition
The specific localisation of ALMS1 to the proximal ends of centrioles  is unusual for a ciliopathy-associated protein. Filaments emanating from this zone make up the centrosome linker, a structure that helps to maintain the close pairing of mother and daughter centrioles, termed centrosome cohesion ([143, 144]; Fig. 2). RNAi data have implicated ALMS1 in the proximal end-recruitment of CEP250/C-Nap1 , a protein that anchors the centrosome linker and a related structure called the ciliary rootlet (Figs. 2 and 5a) [143,144,145]. Consistently, centrosome cohesion appears to be compromised in ALMS1-depleted cells (; Fig. 5a).
There is some evidence that mutations in human CEP250 lead to retinal dystrophy and SNHL [146,147,148], and CEP250 is known to interact with proteins implicated in rhodopsin trafficking (NEK2 and NINL) [149,150,151,152]. It is also worth noting that human Tubby and the core PCP protein Dvl2 localise to the rootlet [153, 154]. CEP250 does not seem to be required for primary cilium formation or maintenance [59, 155,156,157], although a recent conflicting report suggests that ciliogenesis cannot proceed if centrosome cohesion is lost . Another recent study showed that CEP250 contributes to retaining the cilium in a submerged state, affecting its capacity to sense external cues . CEP250 appears to be crucial for the recruitment of several proteins to centriole proximal ends, including Girdin (Girders of actin filaments) and a group of proteins that associate also with the distal region of the mother centriole (NEK2, ninein, CEP170, p150glued and KIF2A) [159,160,161,162]. Thus, recruitment of these proteins to centriole proximal ends may depend indirectly on ALMS1, and there is evidence of this in the case of NEK2 (; Fig. 5a).
In addition to CEP250 and NEK2, centrosomal levels of the PCM protein PCNT are modestly reduced in ALMS1-depleted hTERT-RPE1 cells . Like ALMS1, PCNT has been implicated in ciliogenesis, maintenance of centrosome cohesion and adipogenesis [31, 163, 164]. Moreover, PCNT mutations lead to severe insulin resistance, dyslipidemia and diabetes in the context of microcephalic osteodysplastic primordial dwarfism type 2 (MOPDII) . Centrosomal recruitment of PCNT is mediated in part by polyglutamate chains added post-translationally to centriolar tubulin , making it tempting to speculate that the N-terminal polyglutamate tract of ALMS1 could act in a similar fashion.
It is not hard to imagine ALMS1 performing a structural role such as tethering other proteins to the base of centrioles. Alternatively, it could influence centrosome composition indirectly. Recent data indicate that pericentrosomal levels of centriolar satellites, key regulators of centrosome composition, are enhanced in ALMS1-depleted cells . However, it should be emphasised that the above findings are based on RNAi and await confirmation by rescue experiments and genetic studies.
Actin cytoskeleton organisation
Immunofluorescence analysis of filamentous actin in AS patient fibroblasts revealed the presence of non-uniform and stunted filaments, in addition to stress fibres similar to those of control cells . A separate electron microscopy-based analysis of AS fibroblasts revealed abnormal orientation of microfilaments (a.k.a. actin filaments) . Also of note, these cells displayed a reduced ability to migrate in 3D culture, strong anchoring of cytoplasmic extensions, increased production of extracellular matrix (ECM), an extended cell cycle and resistance to chemically induced apoptosis . It is not known how ALMS1 dysfunction leads to defects in F-actin organisation, although, as noted above, physical interactions with actin-binding/regulatory proteins have been reported [76, 113]. It remains to be investigated if ALMS1 is important for the recently discovered ability of centrosomes to nucleate actin filaments .
Endosomal trafficking of transferrin and Notch
Impairments in the trafficking and recycling of endocytosed transferrin (Tf) have been noted in AS patient fibroblasts . The transferrin receptor showed enhanced accumulation in the pericentrosomal region, while uptake of labelled transferrin was slightly impaired and its exit from the recycling compartment delayed compared to control fibroblasts. The positioning of the pericentrosomal endosomal recycling compartment, marked by Rab11, was unaffected. In the same study, an antibody raised to a C-terminal peptide of murine Alms1 was found to stain the contractile ring and cleavage furrow (sites to which the endosomal recycling machinery is recruited) as well as cytoplasmic ACTN1-immunopositive dense bodies, but not centrosomes, in Madin-Darby canine kidney (MDCK) cells. Based on these and additional data mentioned above, it was speculated that ALMS1 may be required for the cytoskeletal architecture that enables endosomal recycling, and/or function together with the CART complex to facilitate rapid endosome transport along actin filaments (; Fig. 5b).
Endosomal trafficking of Notch, a receptor involved in multiple processes including cell fate determination during development, also appears to be disrupted in ALMS1-deficient cells, although in this case the recycling branch of the pathway was not significantly affected . Specifically, Notch was reported to accumulate in late endosomes in ALMS1-depleted hTERT-RPE1 cells and a slight (1.2-fold) but statistically significant increase in expression of the Notch target gene HES5 was detected in ALMS1-depleted HEK293 cells (Fig. 5b). Overactivation of Notch signalling could have wide-ranging impacts relevant to the pathogenesis of AS including extending the proliferative window of neonatal cardiomyocytes and exacerbating selective insulin resistance in the liver [166, 167]. Notch signalling has been reported to utilise the primary cilium ; however, ALMS1 does not appear to be required for localisation of NOTCH1 to the basal body or cilium . Of note, depletion of BBS proteins similarly leads to accumulation of Notch in late endosomes but also impairs endocytic recycling and basal body/ciliary localisation of the receptor .
GLUT4 trafficking and/or adipogenesis
Indications that ALMS1 influences endocytic recycling suggested that it could have a role in glucose transporter type 4 (GLUT4) trafficking . Insulin-stimulated movement of GLUT4 from intracellular stores to the plasma membrane in fat and muscle cells plays a key role in maintaining whole-body glucose homeostasis . Analysis of adipose tissue from Alms1GT/GT mice revealed that the level of GLUT4 in the plasma membrane fraction was higher in the basal than the insulin-stimulated state, and that the overall level of GLUT4 was reduced compared to control . Moreover, Alms1GT/GT preadipocytes differentiated in vitro showed reduced insulin-stimulated GLUT4 translocation and glucose uptake compared to wild type cells . Phosphorylation of Akt, the main insulin-regulated signal transducer for GLUT4 translocation, appeared to be unaffected in Alms1GT/GT adipose tissue, suggesting that ALMS1 functions either downstream or independently of Akt . The actin cytoskeletal defects observed in patient fibroblasts and the reported physical interaction between Alms1 and Actn4  may provide clues to the underlying mechanism [73, 170]. However, as outlined below, there are conflicting data regarding the importance of Alms1 for insulin-stimulated glucose uptake (and, by implication, GLUT4 trafficking).
Earlier RNAi experiments using 3T3-L1 preadipocytes indicated that Alms1 is important for adipogenic differentiation , whereas preadipocytes from Alms1GT/GT mice showed no such differentiation defect in vitro . This discrepancy may reflect cell line specificity or a difference in the level of residual Alms1 function present, as suggested to explain the ability of patient fibroblasts and Alms1 mutant mice to assemble morphologically normal primary cilia . Of note here, signalling pathways with positive (IGF-1R) and negative (Wnt and Hh) effects on adipogenesis utilise cilia [45, 95, 171], but whether ALMS1 deficiency affects ciliation during this process is not known.
Similar to the later analysis of Alms1GT/GT mouse adipose tissue, Alms1 did not appear to be required for proximal insulin signalling in 3T3-L1 adipocytes . However, neither did it seem to be required for insulin-stimulated glucose uptake, since the modest decreases observed in Alms1-depleted 3T3-L1 adipocytes could be accounted for by impaired differentiation . This study suggests an alternative mechanism contributing to insulin resistance in AS. Namely, that a partial defect in adipogenesis would reduce the ability of adipose tissue to expand in situations of caloric excess, leading to the development of insulin resistance at other sites [79, 172]. However, since the severity of insulin resistance in AS often exceeds that in congenital generalised lipodystrophy, other factors are likely involved .
As noted earlier, ALMS1 has been identified as a potential binding partner of the RNAPII subunit RPB1 . In the same study, punctate nuclear (and cytoplasmic) anti-ALMS1 staining was observed with two different antibodies in cryosections of HeLa cells and murine tissues, and immunolabeling of ALMS1 was found to block subsequent immunolabeling of RPB1, suggesting colocalisation (based on antibody steric hindrance). Supporting the biological relevance of these findings, ALMS1 knockdown reduced global transcription levels in HeLa cells. Thus, these data suggest that ALMS1 localises to the nucleus and is important for sustaining the transcriptional activity of RNAPII . Deficiency of ALMS1 has been associated with altered gene expression profiles in other systems [75, 173, 174]; however, it is unclear if these effects are direct. Of note, the transcriptional program associated with ciliogenesis/confluency was unaffected in Alms1-depleted IMCD3 cells , suggesting that impaired transcription is unlikely to underlie the severe ciliary defects observed in these cells.
Perhaps not surprisingly given the complexity of the AS phenotype, ALMS1 appears to have multiple functions. The photoreceptor phenotype of Alms1GT/GT mice hints at involvement in the transition from vesicular to intraciliary transport, a process controlled in part by the small GTPase Rab8 and in which ciliopathy proteins including CC2D2A and BBS proteins have been implicated [61, 151, 175, 176]. Other studies suggest that ALMS1-deficiency leads to a wider impairment of vesicular transport, affecting Notch signalling, GLUT4-mediated glucose uptake and potentially many other processes. It remains unclear if the underlying cause of these transport deficits is disruption of the actin cytoskeleton (as observed in AS patient fibroblasts), of MTs or of specific trafficking steps. Following up on leads from protein-protein interaction data, recently significantly enriched by a human interactome study , may help to clarify this. Notably, perturbation of either the actin cytoskeleton or the endocytic recycling pathway can affect ciliogenesis and cilium length . However, as discussed earlier, the importance of ALMS1 for cilium structure remains somewhat uncertain, due in part to the lack of obvious ciliary defects in patient-derived fibroblasts.
The application of proximity labelling has raised the intriguing possibility that ALMS1 interacts with centriole assembly factors, similarly to the ALMS motif-containing protein CEP295/KIAA1731. Although centriole-loss has not been observed in ALMS1-deficient cells, a subtler defect, which could affect both ciliary and extraciliary functions of the centrosome, remains a possibility. Loss of the centrosome cohesion protein CEP250/C-Nap1 from ALMS1-depleted centrioles could be a manifestation of such a defect. Indications that ALMS1 has roles in transcription  and possibly the DDR [89, 91] suggest additional areas for further research.
Immunofluorescence data placing ALMS1 at locations such as the nucleus and cleavage furrow support the idea that multiple isoforms of the protein exist. However, it is important to note that these localisation data have yet to be confirmed by, for example, parallel analysis of ALMS1-depleted cells. Further work is needed to explore the range of ALMS1 transcripts produced by cells, their functional capacities and potential relevance to phenotypic variability in AS.
It remains plausible that primary cilium or basal body dysfunction contributes to many aspects of the AS phenotype including obesity, retinal dystrophy, hearing-loss, kidney dysfunction, neurological disturbances and fibrosis [48, 52, 78]. Moreover, data implicating pancreatic β cell primary cilia in the regulation of insulin secretion  raise the possibility that a ciliary defect contributes to the progressive failure of insulin secretion that occurs in AS and is the major factor in progression to diabetes . Dysfunction of motile cilia could contribute to other clinical aspects of AS including respiratory problems, chronic otitis media in childhood and abnormal spinal curvature in adolescence [179, 180]. Although evidence that ALMS1-deficiency directly impacts motile cilia is lacking at present, upregulation of ALMS1 expression during MCC differentiation is intriguing.
Whether a ciliary defect could impair cardiomyocyte cell cycle arrest, leading to infantile DCM/mitogenic cardiomyopathy, is uncertain. Signalling pathways linked to primary cilia in other contexts (e.g. Hippo, Wnt, IGF-1R, Notch) are among the many factors thought to regulate this arrest [167, 181]. However, mammalian cardiomyocytes appear to lose the ability to assemble a primary cilium shortly after birth, concomitant with loss of centrosome integrity and redistribution of centrosomal proteins to the nuclear periphery .
Clearly, much remains to be learned about this giant protein. The identification of bona fide interacting partners remains an important goal, as does, more straightforwardly, confirmation of extra-centrosomal sites of localisation. Structural data may reveal homologies not detectable at the sequence level, helping to reveal the functions of individual domains. The establishment of zebrafish models of AS [80, 173] will facilitate in vivo functional studies, the identification of genetic interactions and therapeutic testing/screening. However, the relatively poor evolutionary conservation of ALMS1 is a limitation of non-mammalian models. Gene editing and the generation of patient-derived induced pluripotent stem cells are likely to play important roles in resolving the functions of the human protein. While this article was in production, it was reported that Alms1 physically interacts with and promotes endocytosis of the renal Na-K-Cl cotransporter NKCC2 in the thick ascending limb (TAL) of the loop of Henle . Alms1 knockout rats developed hypertension (a feature observed in 30% of AS patients ), suggested to be due at least in part to NKCC2 accumulation at the apical cell surface and higher TAL NaCl transport. Kidney tubule primary cilia were reported to be of normal length.
Alström CH, Hallgren B, Nilsson LB, Asander H (1959) Retinal degeneration combined with obesity, diabetes mellitus and neurogenous deafness: a specific syndrome (not hitherto described) distinct from the Laurence-Moon-Bardet-Biedl syndrome: a clinical, endocrinological and genetic examination based on a large pedigree. Acta Psychiatr Neurol Scand 34:1–35
Marshall JD, Maffei P, Collin GB, Naggert JK (2011) Alstrom syndrome: genetics and clinical overview. Curr Genomics 12:225–235
Marshall JD, Beck S, Maffei P, Naggert JK (2007) Alstrom Syndrome. Eur J Hum Genet 15:1193–1202
Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S, Russell-Eggitt I, Shea SE, Davis J, Beck S, Shatirishvili G, Mihai CM, Hoeltzenbein M, Pozzan GB, Hopkinson I, Sicolo N, Naggert JK, Nishina PM (2005) New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med 165:675–683
Boerwinkle C, Marshall JD, Bryant J, Gahl WA, Olivier KN, Gunay-Aygun M (2016) Respiratory manifestations in 38 patients with Alstrom syndrome. Pediatr Pulmonol 52:487–493
Ozanturk A, Marshall JD, Collin GB, Duzenli S, Marshall RP, Candan S, Tos T, Esen I, Taskesen M, Cayir A, Ozturk S, Ustun I, Ataman E, Karaca E, Ozdemir TR, Erol I, Eroglu FK, Torun D, Pariltay E, Yilmaz-Gulec E, Atabek ME, Elcioglu N, Satman I, Moller C, Muller J, Naggert JK, Ozgul RK (2015) The phenotypic and molecular genetic spectrum of Alstrom syndrome in 44 Turkish kindreds and a literature review of Alstrom syndrome in Turkey. J Hum Genet 60:1–9
Brofferio A, Sachdev V, Hannoush H, Marshall JD, Naggert JK, Sidenko S, Noreuil A, Sirajuddin A, Bryant J, Han JC, Arai AE, Gahl WA, Gunay-Aygun M (2017) Characteristics of cardiomyopathy in Alstrom syndrome: prospective single-center data on 38 patients. Mol Genet Metab 121:336–343
O'Rahilly S (2009) Human genetics illuminates the paths to metabolic disease. Nature 462:307–314
Girard D, Petrovsky N (2011) Alstrom syndrome: insights into the pathogenesis of metabolic disorders. Nat Rev Endocrinol 7:77–88
Orphanet (2018) The portal for rare diseases and orphan drugs. http://www.orpha.net. Accessed 16 Oct 2018
Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P, Beck S, Boerkoel CF, Sicolo N, Martin M, Nishina PM, Naggert JK (2002) Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alström syndrome. Nat Genet 31:74–78
Hearn T, Renforth GL, Spalluto C, Hanley NA, Piper K, Brickwood S, White C, Connolly V, Taylor JF, Russell-Eggitt I, Bonneau D, Walker M, Wilson DI (2002) Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alström syndrome. Nat Genet 31:79–83
Astuti D, Sabir A, Fulton P, Zatyka M, Williams D, Hardy C, Milan G, Favaretto F, Yu-Wai-Man P, Rohayem J, de Heredia ML, Hershey T, Tranebjaerg L, Chen JH, Chaussenot A, Nunes V, Marshall B, McAfferty S, Tillmann V, Maffei P, Paquis-Flucklinger V, Geberhiwot T, Mlynarski W, Parkinson K, Picard V, Bueno GE, Dias R, Arnold A, Richens C, Paisey R, Urano F, Semple R, Sinnott R, Barrett TG (2017) Monogenic diabetes syndromes: locus-specific databases for Alstrom, Wolfram and Thiamine-responsive megaloblastic anaemia. Hum Mutat 38:764–777
Marshall JD, Muller J, Collin GB, Milan G, Kingsmore SF, Dinwiddie D, Farrow EG, Miller NA, Favaretto F, Maffei P, Dollfus H, Vettor R, Naggert JK (2015) Alstrom syndrome: mutation spectrum of ALMS1. Hum Mutat 36:660–668
Shenje LT, Andersen P, Halushka MK, Lui C, Fernandez L, Collin GB, Amat-Alarcon N, Meschino W, Cutz E, Chang K, Yonescu R, Batista DA, Chen Y, Chelko S, Crosson JE, Scheel J, Vricella L, Craig BD, Marosy BA, Mohr DW, Hetrick KN, Romm JM, Scott AF, Valle D, Naggert JK, Kwon C, Doheny KF, Judge DP (2014) Mutations in Alstrom protein impair terminal differentiation of cardiomyocytes. Nat Commun 5:3416
Louw JJ, Corveleyn A, Jia Y, Iqbal S, Boshoff D, Gewillig M, Peeters H, Moerman P, Devriendt K (2014) Homozygous loss-of-function mutation in ALMS1 causes the lethal disorder mitogenic cardiomyopathy in two siblings. Eur J Med Genet 57:532–535
Foglia MJ, Poss KD (2016) Building and re-building the heart by cardiomyocyte proliferation. Development 143:729–740
Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M (2003) Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426:570–574
Hearn T, Spalluto C, Phillips VJ, Renforth GL, Copin N, Hanley NA, Wilson DI (2005) Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 54:1581–1587
Nigg EA, Holland AJ (2018) Once and only once: mechanisms of centriole duplication and their deregulation in disease. Nat Rev Mol Cell Biol 19:297–312
Knorz VJ, Spalluto C, Lessard M, Purvis TL, Adigun FF, Collin GB, Hanley NA, Wilson DI, Hearn T (2010) Centriolar association of ALMS1 and likely centrosomal functions of the ALMS motif-containing proteins C10orf90 and KIAA1731. Mol Biol Cell 21:3617–3629
Welte MA (2014) Bidirectional transport along microtubules. Curr Biol 14:R525–R537
Nigg EA, Raff JW (2009) Centrioles, centrosomes, and cilia in health and disease. Cell 139:663–678
Hehnly H, Chen C-T, Powers Christine M, Liu H-L, Doxsey S (2012) The centrosome regulates the Rab11-dependent recycling endosome pathway at appendages of the mother centriole. Curr Biol 22:1944–1950
Farina F, Gaillard J, Guerin C, Coute Y, Sillibourne J, Blanchoin L, Thery M (2016) The centrosome is an actin-organizing centre. Nat Cell Biol 18:65–75
Stinchcombe JC, Griffiths GM (2014) Communication, the centrosome and the immunological synapse. Philos Trans R Soc Lond Ser B Biol Sci 369:20130463
Vora SM, Phillips BT (2016) The benefits of local depletion: the centrosome as a scaffold for ubiquitin-proteasome-mediated degradation. Cell Cycle 15:2124–2134
Mullee LI, Morrison CG (2016) Centrosomes in the DNA damage response - the hub outside the centre. Chromosom Res 24:35–51
Arquint C, Gabryjonczyk A-M, Nigg EA (2014) Centrosomes as signalling centres. Philos Trans R Soc Lond Ser B Biol Sci 369:20130464
Chen JH, Segni M, Payne F, Huang-Doran I, Sleigh A, Adams C, Savage DB, O'Rahilly S, Semple RK, Barroso I (2015) Truncation of POC1A associated with short stature and extreme insulin resistance. J Mol Endocrinol 55:147–158
Huang-Doran I, Bicknell LS, Finucane FM, Rocha N, Porter KM, YCL T, Szekeres F, Krook A, Nolan JJ, O’Driscoll M, Bober M, O’Rahilly S, Jackson AP, Semple RK (2011) Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes. Diabetes 60:925–935
Shalata A, Ramirez MC, Desnick RJ, Priedigkeit N, Buettner C, Lindtner C, Mahroum M, Abdul-Ghani M, Dong F, Arar N, Camacho-Vanegas O, Zhang R, Camacho SC, Chen Y, Ibdah M, DeFronzo R, Gillespie V, Kelley K, Dynlacht BD, Kim S, Glucksman MJ, Borochowitz ZU, Martignetti JA (2013) Morbid obesity resulting from inactivation of the ciliary protein CEP19 in humans and mice. Am J Hum Genet 93:1061–1071
Ishikawa H, Marshall WF (2011) Ciliogenesis: building the cell's antenna. Nat Rev Mol Cell Biol 12:222–234
Benmerah A (2014) The ciliary pocket. Curr Opin Cell Biol 25:78–84
Garcia-Gonzalo FR, Reiter JF (2017) Open sesame: how transition fibers and the transition zone control ciliary composition. Cold Spring Harb Perspect Biol 9:a028134
Molday RS, Moritz OL (2015) Photoreceptors at a glance. J Cell Sci 128:4039–4045
Schwander M, Kachar B, Muller U (2010) The cell biology of hearing. J Cell Biol 190:9–20
Jones C, Roper VC, Foucher I, Qian D, Banizs B, Petit C, Yoder BK, Chen P (2008) Ciliary proteins link basal body polarization to planar cell polarity regulation. Nat Genet 40:69–77
Fry AM, Leaper MJ, Bayliss R (2014) The primary cilium: guardian of organ development and homeostasis. Organogenesis 10:62–68
Mariman EC, Vink RG, Roumans NJ, Bouwman FG, Stumpel CT, Aller EE, van Baak MA, Wang P (2016) The cilium: a cellular antenna with an influence on obesity risk. Br J Nutr 116:576–592
Oh EC, Vasanth S, Katsanis N (2015) Metabolic regulation and energy homeostasis through the primary cilium. Cell Metab 21:21–31
Bangs F, Anderson KV (2017) Primary cilia and mammalian hedgehog signaling. Cold Spring Harb Perspect Biol 9:a028175
Schneider L, Clement CA, Teilmann SC, Pazour GJ, Hoffmann EK, Satir P, Christensen ST (2005) PDGFRαα signaling is regulated through the primary cilium in fibroblasts. Curr Biol 15:1861–1866
Yeh C, Li A, Chuang J-Z, Saito M, Cáceres A, Sung C-H (2013) IGF-1 activates a cilium-localized noncanonical Gβγ signaling pathway that regulates cell-cycle progression. Dev Cell 26:358–368
Zhu D, Shi S, Wang H, Liao K (2009) Growth arrest induces primary-cilium formation and sensitizes IGF-1-receptor signaling during differentiation induction of 3T3-L1 preadipocytes. J Cell Sci 122:2760–2768
Christensen ST, Morthorst SK, Mogensen JB, Pedersen LB (2017) Primary cilia and coordination of receptor tyrosine kinase (RTK) and transforming growth factor beta (TGF-beta) signaling. Cold Spring Harb Perspect Biol 9:a028167
Hilgendorf KI, Johnson CT, Jackson PK (2016) The primary cilium as a cellular receiver: organizing ciliary GPCR signaling. Curr Opin Cell Biol 39:84–92
Seeger-Nukpezah T, Golemis EA (2012) The extracellular matrix and ciliary signaling. Curr Opin Cell Biol 24:652–661
Spasic M, Jacobs CR (2017) Primary cilia: cell and molecular mechanosensors directing whole tissue function. Semin Cell Dev Biol 71:42–52
Delling M, Indzhykulian AA, Liu X, Li Y, Xie T, Corey DP, Clapham DE (2016) Primary cilia are not calcium-responsive mechanosensors. Nature 531:656–660
Malicki JJ, Johnson CA (2016) The cilium: cellular antenna and central processing unit. Trends Cell Biol 27:126–140
Reiter JF, Leroux MR (2017) Genes and molecular pathways underpinning ciliopathies. Nat Rev Mol Cell Biol 18:533–547
Braun DA, Hildebrandt F (2017) Ciliopathies. Cold Spring Harb Perspect Biol 9:a028191
Mitchison HM, Valente EM (2017) Motile and non-motile cilia in human pathology: from function to phenotypes. J Pathol 241:294–309
Novarino G, Akizu N, Gleeson JG (2011) Modeling human disease in humans: the ciliopathies. Cell 147:70–79
Jagger D, Collin G, Kelly J, Towers E, Nevill G, Longo-Guess C, Benson J, Halsey K, Dolan D, Marshall J, Naggert J, Forge A (2010) Alstrom syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity. Hum Mol Genet 20:466–481
Li G, Vega R, Nelms K, Gekakis N, Goodnow C, McNamara P, Wu H, Hong NA, Glynne R (2007) A role for Alstrom syndrome protein, Alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet 3:e8
Heydet D, Chen LX, Larter CZ, Inglis C, Silverman MA, Farrell GC, Leroux MR (2013) A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice. Dev Neurobiol 73:1–13
Graser S, Stierhof YD, Lavoie SB, Gassner OS, Lamla S, Le Clech M, Nigg EA (2007) Cep164, a novel centriole appendage protein required for primary cilium formation. J Cell Biol 179:321–330
Pereiro I, Hoskins BE, Marshall JD, Collin GB, Naggert JK, Pineiro-Gallego T, Oitmaa E, Katsanis N, Valverde D, Beales PL (2011) Arrayed primer extension technology simplifies mutation detection in Bardet-Biedl and Alstrom syndrome. Eur J Hum Genet 19:485–488
Nachury MV, Loktev AV, Zhang Q, Westlake CJ, Peranen J, Merdes A, Slusarski DC, Scheller RH, Bazan JF, Sheffield VC, Jackson PK (2007) A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. Cell 129:1201–1213
Seo S, Baye LM, Schulz NP, Beck JS, Zhang Q, Slusarski DC, Sheffield VC (2010) BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly. Proc Natl Acad Sci U S A 107:1488–1493
Wei Q, Zhang Y, Li Y, Zhang Q, Ling K, Hu J (2012) The BBSome controls IFT assembly and turnaround in cilia. Nat Cell Biol 14:950–957
Lechtreck KF, Johnson EC, Sakai T, Cochran D, Ballif BA, Rush J, Pazour GJ, Ikebe M, Witman GB (2009) The Chlamydomonas reinhardtii BBSome is an IFT cargo required for export of specific signaling proteins from flagella. J Cell Biol 187:1117–1132
Jin H, White SR, Shida T, Schulz S, Aguiar M, Gygi SP, Bazan JF, Nachury MV (2010) The conserved Bardet-Biedl syndrome proteins assemble a coat that traffics membrane proteins to cilia. Cell 141:1208–1219
Starks RD, Beyer AM, Guo DF, Boland L, Zhang Q, Sheffield VC, Rahmouni K (2015) Regulation of insulin receptor trafficking by Bardet Biedl syndrome proteins. PLoS Genet 11:e1005311
Guo D-F, Cui H, Zhang Q, Morgan DA, Thedens DR, Nishimura D, Grobe JL, Sheffield VC, Rahmouni K (2016) The BBSome controls energy homeostasis by mediating the transport of the leptin receptor to the plasma membrane. PLoS Genet 12:e1005890
Kleyn PW, Fan W, Kovats SG, Lee JJ, Pulido JC, Wu Y, Berkemeier LR, Misumi DJ, Holmgren L, Charlat O, Woolf EA, Tayber O, Brody T, Shu P, Hawkins F, Kennedy B, Baldini L, Ebeling C, Alperin GD, Deeds J, Lakey ND, Culpepper J, Chen H, Glucksmann-Kuis MA, Carlson GA, Duyk GM, Moore KJ (1996) Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 85:281–290
Noben-Trauth K, Naggert JK, North MA, Nishina PM (1996) A candidate gene for the mouse mutation tubby. Nature 380:534–538
Park J, Lee J, Shim J, Han W, Lee J, Bae YC, Chung YD, Kim CH, Moon SJ (2013) dTULP, the Drosophila melanogaster homolog of tubby, regulates transient receptor potential channel localization in cilia. PLoS Genet 9:e1003814
Sun X, Haley J, Bulgakov O, Cai X, McGinnis J, Li T (2012) Tubby is required for trafficking G protein-coupled receptors to neuronal cilia. Cilia 1:21
Santagata S, Boggon TJ, Baird CL, Gomez CA, Zhao J, Shan WS, Myszka DG, Shapiro L (2001) G-protein signaling through tubby proteins. Science 292:2041–2050
Favaretto F, Milan G, Collin GB, Marshall JD, Stasi F, Maffei P, Vettor R, Naggert JK (2014) GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance. PLoS One 9:e109540
Leitch CC, Lodh S, Prieto-Echague V, Badano JL, Zaghloul NA (2014) Basal body proteins regulate notch signaling through endosomal trafficking. J Cell Sci 127:2407–2419
Zulato E, Favaretto F, Veronese C, Campanaro S, Marshall JD, Romano S, Cabrelle A, Collin GB, Zavan B, Belloni AS, Rampazzo E, Naggert JK, Abatangelo G, Sicolo N, Maffei P, Milan G, Vettor R (2011) ALMS1-deficient fibroblasts over-express extra-cellular matrix components, display cell cycle delay and are resistant to apoptosis. PLoS One 6:e19081
Collin GB, Marshall JD, King BL, Milan G, Maffei P, Jagger DJ, Naggert JK (2012) The Alstrom syndrome protein, ALMS1, interacts with alpha-actinin and components of the endosome recycling pathway. PLoS One 7:e37925
Moller A, Xie SQ, Hosp F, Lang B, Phatnani HP, James S, Ramirez F, Collin GB, Naggert JK, Babu MM, Greenleaf AL, Selbach M, Pombo A (2012) Proteomic analysis of mitotic RNA polymerase II reveals novel interactors and association with proteins dysfunctional in disease. Mol Cell Proteomics 11:M111.011767
Guo J, Higginbotham H, Li J, Nichols J, Hirt J, Ghukasyan V, Anton ES (2015) Developmental disruptions underlying brain abnormalities in ciliopathies. Nat Commun 6:7857
Huang-Doran I, Semple RK (2010) Knockdown of the Alstrom syndrome-associated gene Alms1 in 3T3-L1 preadipocytes impairs adipogenesis but has no effect on cell-autonomous insulin action. Int J Obes 34:1554–1558
Lodh S, Hostelley TL, Leitch CC, O'Hare EA, Zaghloul NA (2016) Differential effects on beta-cell mass by disruption of Bardet-Biedl syndrome or Alstrom syndrome genes. Hum Mol Genet 25:57–68
Poekes L, Legry V, Schakman O, Detrembleur C, Bol A, Horsmans Y, Farrell GC, Leclercq IA (2017) Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice. Clin Sci 131:285–296
Arsov T, Silva DG, O’Bryan MK, Sainsbury A, Lee NJ, Kennedy C, Manji SS, Nelms K, Liu C, Vinuesa CG, de Kretser DM, Goodnow CC, Petrovsky N (2006) Fat Aussie - a new Alstrom syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol Endocrinol 20:1610–1622
Yan S, Qiu L, Ma K, Zhang X, Zhao Y, Zhang J, Li X, Hao X, Li Z (2014) FATS is an E2-independent ubiquitin ligase that stabilizes p53 and promotes its activation in response to DNA damage. Oncogene 33:5424–5433
Chang CW, Hsu WB, Tsai JJ, Tang CC, Tang TK (2016) CEP295 interacts with microtubules and is required for centriole elongation. J Cell Sci 129:2501–2513
Tsuchiya Y, Yoshiba S, Gupta A, Watanabe K, Kitagawa D (2016) Cep295 is a conserved scaffold protein required for generation of a bona fide mother centriole. Nat Commun 7:12567
Izquierdo D, Wang WJ, Uryu K, Tsou MF (2014) Stabilization of cartwheel-less centrioles for duplication requires CEP295-mediated centriole-to-centrosome conversion. Cell Rep 8:957–965
Fu J, Lipinszki Z, Rangone H, Min M, Mykura C, Chao-Chu J, Schneider S, Dzhindzhev NS, Gottardo M, Riparbelli MG, Callaini G, Glover DM (2016) Conserved molecular interactions in centriole-to-centrosome conversion. Nat Cell Biol 18:87–99
Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA (2013) Integrated proteomic analysis of post-translational modifications by serial enrichment. Nat Methods 10:634–637
Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160–1166
Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E (2015) PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res 43:D512–D520
Hurov KE, Cotta-Ramusino C, Elledge SJ (2010) A genetic screen identifies the triple T complex required for DNA damage signaling and ATM and ATR stability. Genes Dev 24:1939–1950
Chaki M, Airik R, Ghosh AK, Giles RH, Chen R, Slaats GG, Wang H, Hurd TW, Zhou W, Cluckey A, Gee HY, Ramaswami G, Hong CJ, Hamilton BA, Cervenka I, Ganji RS, Bryja V, Arts HH, van Reeuwijk J, Oud MM, Letteboer SJ, Roepman R, Husson H, Ibraghimov-Beskrovnaya O, Yasunaga T, Walz G, Eley L, Sayer JA, Schermer B, Liebau MC, Benzing T, Le Corre S, Drummond I, Janssen S, Allen SJ, Natarajan S, O'Toole JF, Attanasio M, Saunier S, Antignac C, Koenekoop RK, Ren H, Lopez I, Nayir A, Stoetzel C, Dollfus H, Massoudi R, Gleeson JG, Andreoli SP, Doherty DG, Lindstrad A, Golzio C, Katsanis N, Pape L, Abboud EB, Al-Rajhi AA, Lewis RA, Omran H, Lee EY, Wang S, Sekiguchi JM, Saunders R, Johnson CA, Garner E, Vanselow K, Andersen JS, Shlomai J, Nurnberg G, Nurnberg P, Levy S, Smogorzewska A, Otto EA, Hildebrandt F (2012) Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell 150:533–548
Collin GB, Cyr E, Bronson R, Marshall JD, Gifford EJ, Hicks W, Murray SA, Zheng QY, Smith RS, Nishina PM, Naggert JK (2005) Alms1-disrupted mice recapitulate human Alstrom syndrome. Hum Mol Genet 14:2323–2333
Romano S, Milan G, Veronese C, Collin GB, Marshall JD, Centobene C, Favaretto F, Dal Pra C, Scarda A, Leandri S, Naggert JK, Maffei P, Vettor R (2008) Regulation of Alstrom syndrome gene expression during adipogenesis and its relationship with fat cell insulin sensitivity. Int J Mol Med 21:731–736
Marion V, Stoetzel C, Schlicht D, Messaddeq N, Koch M, Flori E, Danse JM, Mandel JL, Dollfus H (2009) Transient ciliogenesis involving Bardet-Biedl syndrome proteins is a fundamental characteristic of adipogenic differentiation. Proc Natl Acad Sci U S A 106:1820–1825
Purvis TL, Hearn T, Spalluto C, Knorz VJ, Hanley KP, Sanchez-Elsner T, Hanley NA, Wilson DI (2010) Transcriptional regulation of the Alström syndrome gene ALMS1 by members of the RFX family and Sp1. Gene 460:20–29
Yabuta N, Onda H, Watanabe M, Yoshioka N, Nagamori I, Funatsu T, Toji S, Tamai K, Nojima H (2006) Isolation and characterization of the TIGA genes, whose transcripts are induced by growth arrest. Nucleic Acids Res 34:4878–4892
Hoh RA, Stowe TR, Turk E, Stearns T (2012) Transcriptional program of ciliated epithelial cells reveals new cilium and centrosome components and links to human disease. PLoS One 7:e52166
Ma L, Quigley I, Omran H, Kintner C (2014) Multicilin drives centriole biogenesis via E2f proteins. Genes Dev 28:1461–1471
Elkon R, Milon B, Morrison L, Shah M, Vijayakumar S, Racherla M, Leitch CC, Silipino L, Hadi S, Weiss-Gayet M, Barras E, Schmid CD, Ait-Lounis A, Barnes A, Song Y, Eisenman DJ, Eliyahu E, Frolenkov GI, Strome SE, Durand B, Zaghloul NA, Jones SM, Reith W, Hertzano R (2015) RFX transcription factors are essential for hearing in mice. Nat Commun 6:8549
Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R (2010) Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 107:21931–21936
Mei S, Qin Q, Wu Q, Sun H, Zheng R, Zang C, Zhu M, Wu J, Shi X, Taing L, Liu T, Brown M, Meyer CA, Liu XS (2017) Cistrome data browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse. Nucleic Acids Res 45:D658–D662
Choksi SP, Lauter G, Swoboda P, Roy S (2014) Switching on cilia: transcriptional networks regulating ciliogenesis. Development 141:1427–1441
Kang GM, Han YM, Ko HW, Kim J, Oh BC, Kwon I, Kim M-S (2015) Leptin elongates hypothalamic neuronal cilia via transcriptional regulation and actin destabilization. J Biol Chem 290:18146–18155
Tammimies K, Bieder A, Lauter G, Sugiaman-Trapman D, Torchet R, Hokkanen M-E, Burghoorn J, Castren E, Kere J, Tapia-Paez I, Swoboda P (2016) Ciliary dyslexia candidate genes DYX1C1 and DCDC2 are regulated by regulatory factor (RF) X transcription factors through X-box promoter motifs. FASEB J 30:3578–3587
Thomas J, Morlé L, Soulavie F, Laurençon A, Sagnol S, Durand B (2010) Transcriptional control of genes involved in ciliogenesis: a first step in making cilia. Biol Cell 102:499–513
Yan Q, Sun W, Kujala P, Lotfi Y, Vida TA, Bean AJ (2005) CART: an Hrs/actinin-4/BERP/myosin V protein complex required for efficient receptor recycling. Mol Biol Cell 16:2470–2482
Lapierre LA, Kumar R, Hales CM, Navarre J, Bhartur SG, Burnette JO, Provance DW, Mercer JA, Bahler M, Goldenring JR (2001) Myosin Vb is associated with plasma membrane recycling systems. Mol Biol Cell 12:1843–1857
Assis LH, Silva-Junior RM, Dolce LG, Alborghetti MR, Honorato RV, Nascimento AF, Melo-Hanchuk TD, Trindade DM, Tonoli CC, Santos CT, Oliveira PS, Larson RE, Kobarg J, Espreafico EM, Giuseppe PO, Murakami MT (2017) The molecular motor myosin Va interacts with the cilia-centrosomal protein RPGRIP1L. Sci Rep 7:43692
Schaub JR, Stearns T (2013) The Rilp-like proteins Rilpl1 and Rilpl2 regulate ciliary membrane content. Mol Biol Cell 24:453–464
Kohli P, Hohne M, Jungst C, Bertsch S, Ebert LK, Schauss AC, Benzing T, Rinschen MM, Schermer B (2017) The ciliary membrane-associated proteome reveals actin-binding proteins as key components of cilia. EMBO Rep 18:1521–1535
Huttlin EL, Ting L, Bruckner RJ, Gebreab F, Gygi MP, Szpyt J, Tam S, Zarraga G, Colby G, Baltier K, Dong R, Guarani V, Vaites LP, Ordureau A, Rad R, Erickson BK, Wuhr M, Chick J, Zhai B, Kolippakkam D, Mintseris J, Obar RA, Harris T, Artavanis-Tsakonas S, Sowa ME, De Camilli P, Paulo JA, Harper JW, Gygi SP (2015) The BioPlex network: a systematic exploration of the human Interactome. Cell 162:425–440
Huttlin EL, Bruckner RJ, Paulo JA, Cannon JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, Szpyt J, Tam S, Zarraga G, Pontano-Vaites L, Swarup S, White AE, Schweppe DK, Rad R, Erickson BK, Obar RA, Guruharsha KG, Li K, Artavanis-Tsakonas S, Gygi SP, Harper JW (2017) Architecture of the human interactome defines protein communities and disease networks. Nature 545:505–509
Kim J, Lee JE, Heynen-Genel S, Suyama E, Ono K, Lee K, Ideker T, Aza-Blanc P, Gleeson JG (2010) Functional genomic screen for modulators of ciliogenesis and cilium length. Nature 464:1048–1051
Lo JCY, Jamsai D, O’Connor AE, Borg C, Clark BJ, Whisstock JC, Field MC, Adams V, Ishikawa T, Aitken RJ, Whittle B, Goodnow CC, Ormandy CJ, O’Bryan MK (2012) RAB-like 2 has an essential role in male fertility, sperm intra-flagellar transport, and tail assembly. PLoS Genet 8:e1002969
Kanie T, Abbott KL, Mooney NA, Plowey ED, Demeter J, Jackson PK (2017) The CEP19-RABL2 GTPase complex binds IFT-B to initiate intraflagellar transport at the ciliary base. Dev Cell 42:22–36
Nishijima Y, Hagiya Y, Kubo T, Takei R, Katoh Y, Nakayama K (2017) RABL2 interacts with the IFT-B complex and CEP19, and participates in ciliary assembly. Mol Biol Cell 28:1652–1666
Antonny B, Burd C, De Camilli P, Chen E, Daumke O, Faelber K, Ford M, Frolov VA, Frost A, Hinshaw JE, Kirchhausen T, Kozlov MM, Lenz M, Low HH, McMahon H, Merrifield C, Pollard TD, Robinson PJ, Roux A, Schmid S (2016) Membrane fission by dynamin: what we know and what we need to know. EMBO J 35:2270–2284
Milton A, Luoto K, Ingram L, Munro S, Logan N, Graham AL, Brummelkamp TR, Hijmans EM, Bernards R, La Thangue NB (2006) A functionally distinct member of the DP family of E2F subunits. Oncogene 25:3212
Delevoye C, Heiligenstein X, Ripoll L, Gilles-Marsens F, Dennis MK, Linares RA, Derman L, Gokhale A, Morel E, Faundez V, Marks MS, Raposo G (2016) BLOC-1 brings together the actin and microtubule cytoskeletons to generate recycling endosomes. Curr Biol 26:1–13
Marley A, von Zastrow M (2010) Dysbindin promotes the post-endocytic sorting of G protein-coupled receptors to lysosomes. PLoS One 5:e9325
Monis WJ, Faundez V, Pazour GJ (2017) BLOC-1 is required for selective membrane protein trafficking from endosomes to primary cilia. J Cell Biol 216:2131–2150
Hein MY, Hubner NC, Poser I, Cox J, Nagaraj N, Toyoda Y, Gak IA, Weisswange I, Mansfeld J, Buchholz F, Hyman AA, Mann M (2015) A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 163:712–723
Wang Y, Satoh A, Warren G, Meyer HH (2004) VCIP135 acts as a deubiquitinating enzyme during p97-p47-mediated reassembly of mitotic Golgi fragments. J Cell Biol 164:973–978
Uchiyama K, Jokitalo E, Kano F, Murata M, Zhang X, Canas B, Newman R, Rabouille C, Pappin D, Freemont P, Kondo H (2002) VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J Cell Biol 159:855–866
Varjosalo M, Keskitalo S, VanÂ Drogen A, Nurkkala H, Vichalkovski A, Aebersold R, Gstaiger M (2013) The protein interaction landscape of the human CMGC kinase group. Cell Rep 3:1306–1320
Jung B, Padula D, Burtscher I, Landerer C, Lutter D, Theis F, Messias AC, Geerlof A, Sattler M, Kremmer E, Boldt K, Ueffing M, Lickert H (2016) Pitchfork and Gprasp2 target smoothened to the primary cilium for hedgehog pathway activation. PLoS One 11:e0149477
Li S, Wang L, Fu B, Berman MA, Diallo A, Dorf ME (2014) TRIM65 regulates microRNA activity by ubiquitination of TNRC6. Proc Natl Acad Sci U S A 111:6970–6975
Gomez-Ferreria MA, Bashkurov M, Mullin M, Gingras A-C, Pelletier L (2012) CEP192 interacts physically and functionally with the K63-deubiquitinase CYLD to promote mitotic spindle assembly. Cell Cycle 11:3555–3558
Firat-Karalar EN, Rauniyar N, Yates JR 3rd, Stearns T (2014) Proximity interactions among centrosome components identify regulators of centriole duplication. Curr Biol 24:664–670
Gupta GD, Coyaud E, Goncalves J, Mojarad BA, Liu Y, Wu Q, Gheiratmand L, Comartin D, Tkach JM, Cheung SW, Bashkurov M, Hasegan M, Knight JD, Lin ZY, Schueler M, Hildebrandt F, Moffat J, Gingras AC, Raught B, Pelletier L (2015) A dynamic protein interaction landscape of the human centrosome-cilium interface. Cell 163:1484–1499
Coyaud E, Mis M, Laurent EMN, Dunham WH, Couzens AL, Robitaille M, Gingras A-C, Angers S, Raught B (2015) BioID-based identification of Skp Cullin F-box (SCF)beta-TrCP1/2 E3 ligase substrates. Mol Cell Proteomics 14:1781–1795
Agircan FG, Hata S, Nussbaum-Krammer C, Atorino E, Schiebel E (2016) Proximity mapping of human separase by the BioID approach. Biochem Biophys Res Commun 478:656–662
Tsou MF, Stearns T (2006) Mechanism limiting centrosome duplication to once per cell cycle. Nature 442:947–951
Couzens AL, Knight JDR, Kean MJ, Teo G, Weiss A, Dunham WH, Lin Z-Y, Bagshaw RD, Sicheri F, Pawson T, Wrana JL, Choi H, Gingras A-C (2013) Protein interaction network of the mammalian hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci Signal 6:rs15-rs15
Chatr-aryamontri A, Oughtred R, Boucher L, Rust J, Chang C, Kolas NK, O'Donnell L, Oster S, Theesfeld C, Sellam A, Stark C, Breitkreutz B-J, Dolinski K, Tyers M (2017) The BioGRID interaction database: 2017 update. Nucleic Acids Res 45:D369–D379
Ansley SJ, Badano JL, Blacque OE, Hill J, Hoskins BE, Leitch CC, Kim JC, Ross AJ, Eichers ER, Teslovich TM, Mah AK, Johnsen RC, Cavender JC, Lewis RA, Leroux MR, Beales PL, Katsanis N (2003) Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 425:628–633
Ross AJ, May-Simera H, Eichers ER, Kai M, Hill J, Jagger DJ, Leitch CC, Chapple JP, Munro PM, Fisher S, Tan PL, Phillips HM, Leroux MR, Henderson DJ, Murdoch JN, Copp AJ, Eliot MM, Lupski JR, Kemp DT, Dollfus H, Tada M, Katsanis N, Forge A, Beales PL (2005) Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. Nat Genet 37:1135–1140
Berbari NF, Lewis JS, Bishop GA, Askwith CC, Mykytyn K (2008) Bardet-Biedl syndrome proteins are required for the localization of G protein-coupled receptors to primary cilia. Proc Natl Acad Sci U S A 105:4242–4246
Wang Z, Li V, Chan GC, Phan T, Nudelman AS, Xia Z, Storm DR (2009) Adult type 3 adenylyl cyclase-deficient mice are obese. PLoS One 4:e6979
Davenport JR, Watts AJ, Roper VC, Croyle MJ, van Groen T, Wyss JM, Nagy TR, Kesterson RA, Yoder BK (2007) Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr Biol 17:1586–1594
Chen JH, Geberhiwot T, Barrett TG, Paisey R, Semple RK (2017) Refining genotype-phenotype correlation in Alstrom syndrome through study of primary human fibroblasts. Mol Genet Genomic Med 5:390–404
Bahe S, Stierhof YD, Wilkinson CJ, Leiss F, Nigg EA (2005) Rootletin forms centriole-associated filaments and functions in centrosome cohesion. J Cell Biol 171:27–33
Yang J, Adamian M, Li T (2006) Rootletin interacts with C-Nap1 and may function as a physical linker between the pair of centrioles/basal bodies in cells. Mol Biol Cell 17:1033–1040
Mayor T, Stierhof YD, Tanaka K, Fry AM, Nigg EA (2000) The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. J Cell Biol 151:837–846
Khateb S, Zelinger L, Mizrahi-Meissonnier L, Ayuso C, Koenekoop RK, Laxer U, Gross M, Banin E, Sharon D (2014) A homozygous nonsense CEP250 mutation combined with a heterozygous nonsense C2orf71 mutation is associated with atypical Usher syndrome. J Med Genet 51:460–469
de Castro-Miro M, Tonda R, Escudero-Ferruz P, Andres R, Mayor-Lorenzo A, Castro J, Ciccioli M, Hidalgo DA, Rodriguez-Ezcurra JJ, Farrando J, Perez-Santonja JJ, Cormand B, Marfany G, Gonzalez-Duarte R (2016) Novel candidate genes and a wide spectrum of structural and point mutations responsible for inherited retinal dystrophies revealed by exome sequencing. PLoS One 11:e0168966
Kubota D, Gocho K, Kikuchi S, Akeo K, Miura M, Yamaki K, Takahashi H, Kameya S (2018) CEP250 mutations associated with mild cone-rod dystrophy and sensorineural hearing loss in a Japanese family. Ophthalmic Genet 39:500–507
Fogeron ML, Muller H, Schade S, Dreher F, Lehmann V, Kuhnel A, Scholz AK, Kashofer K, Zerck A, Fauler B, Lurz R, Herwig R, Zatloukal K, Lehrach H, Gobom J, Nordhoff E, Lange BM (2013) LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. Nat Commun 4:1531
Fry AM, Mayor T, Meraldi P, Stierhof YD, Tanaka K, Nigg EA (1998) C-Nap1, a novel centrosomal coiled-coil protein and candidate substrate of the cell cycle-regulated protein kinase Nek2. J Cell Biol 141:1563–1574
Bachmann-Gagescu R, Dona M, Hetterschijt L, Tonnaer E, Peters T, de Vrieze E, Mans DA, van Beersum SEC, Phelps IG, Arts HH, Keunen JE, Ueffing M, Roepman R, Boldt K, Doherty D, Moens CB, Neuhauss SCF, Kremer H, van Wijk E (2015) The ciliopathy protein CC2D2A associates with NINL and functions in RAB8-MICAL3-regulated vesicle trafficking. PLoS Genet 11:e1005575
Nishiguchi KM, Tearle RG, Liu YP, Oh EC, Miyake N, Benaglio P, Harper S, Koskiniemi-Kuendig H, Venturini G, Sharon D, Koenekoop RK, Nakamura M, Kondo M, Ueno S, Yasuma TR, Beckmann JS, Ikegawa S, Matsumoto N, Terasaki H, Berson EL, Katsanis N, Rivolta C (2013) Whole genome sequencing in patients with retinitis pigmentosa reveals pathogenic DNA structural changes and NEK2 as a new disease gene. Proc Natl Acad Sci U S A 110:16139–16144
Borman AD, Pearce LR, Mackay DS, Nagel-Wolfrum K, Davidson AE, Henderson R, Garg S, Waseem NH, Webster AR, Plagnol V, Wolfrum U, Farooqi IS, Moore AT (2014) A homozygous mutation in the TUB gene associated with retinal dystrophy and obesity. Hum Mutat 35:289–293
Park TJ, Mitchell BJ, Abitua PB, Kintner C, Wallingford JB (2008) Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells. Nat Genet 40:871–879
Panic M, Hata S, Neuner A, Schiebel E (2015) The centrosomal linker and microtubules provide dual levels of spatial coordination of centrosomes. PLoS Genet 11:e1005243
Floriot S, Vesque C, Rodriguez S, Bourgain-Guglielmetti F, Karaiskou A, Gautier M, Duchesne A, Barbey S, Fritz S, Vasilescu A, Bertaud M, Moudjou M, Halliez S, Cormier-Daire V, J ELH, Nigg EA, Manciaux L, Guatteo R, Cesbron N, Toutirais G, Eggen A, Schneider-Maunoury S, Boichard D, Sobczak-Thepot J, Schibler L (2015) C-Nap1 mutation affects centriole cohesion and is associated with a Seckel-like syndrome in cattle. Nat Commun 6:6894
Flanagan AM, Stavenschi E, Basavaraju S, Gaboriau D, Hoey DA, Morrison CG (2017) Centriole splitting caused by loss of the centrosomal linker protein C-NAP1 reduces centriolar satellite density and impedes centrosome amplification. Mol Biol Cell 28:736–745
Loukil A, Tormanen K, Sutterlin C (2017) The daughter centriole controls ciliogenesis by regulating Neurl-4 localization at the centrosome. J Cell Biol 216:1287–1300
Mazo G, Soplop N, Wang WJ, Uryu K, Tsou MB (2016) Spatial control of primary ciliogenesis by subdistal appendages alters sensation-associated properties of cilia. Dev Cell 39:424–437
Nechipurenko IV, Olivier-Mason A, Kazatskaya A, Kennedy J, McLachlan IG, Heiman MG, Blacque OE, Sengupta P (2016) A conserved role for Girdin in basal body positioning and ciliogenesis. Dev Cell 38:493–506
Hardy T, Lee M, Hames RS, Prosser SL, Cheary D-M, Samant MD, Schultz F, Baxter JE, Rhee K, Fry AM (2014) Multisite phosphorylation of C-Nap1 releases it from Cep135 to trigger centrosome disjunction. J Cell Sci 127:2493–2506
Spalluto C, Wilson DI, Hearn T (2012) Nek2 localises to the distal portion of the mother centriole/basal body and is required for timely cilium disassembly at the G2/M transition. Eur J Cell Biol 91:675–686
Jurczyk A, Gromley A, Redick S, San Agustin J, Witman G, Pazour GJ, Peters DJ, Doxsey S (2004) Pericentrin forms a complex with intraflagellar transport proteins and polycystin-2 and is required for primary cilia assembly. J Cell Biol 166:637–643
Graser S, Stierhof YD, Nigg EA (2007) Cep68 and Cep215 (Cdk5rap2) are required for centrosome cohesion. J Cell Sci 120:4321–4331
Madarampalli B, Yuan Y, Liu D, Lengel K, Xu Y, Li G, Yang J, Liu X, Lu Z, Liu DX (2015) ATF5 connects the pericentriolar materials to the proximal end of the mother centriole. Cell 162:580–592
Bi P, Kuang S (2015) Notch signaling as a novel regulator of metabolism. Trends Endocrinol Metab 26:248–255
Collesi C, Zentilin L, Sinagra G, Giacca M (2008) Notch1 signaling stimulates proliferation of immature cardiomyocytes. J Cell Biol 183:117–128
Ezratty EJ, Stokes N, Chai S, Shah AS, Williams SE, Fuchs E (2011) A role for the primary cilium in Notch signaling and epidermal differentiation during skin development. Cell 145:1129–1141
Leto D, Saltiel AR (2012) Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13:383–396
Talior-Volodarsky I, Randhawa VK, Zaid H, Klip A (2008) Alpha-actinin-4 is selectively required for insulin-induced GLUT4 translocation. J Biol Chem 283:25115–25123
Lowe CE, O'Rahilly S, Rochford JJ (2011) Adipogenesis at a glance. J Cell Sci 124:2681–2686
Gustafson B, Hedjazifar S, Gogg S, Hammarstedt A, Smith U (2015) Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab 26:193–200
Hostelley TL, Lodh S, Zaghloul NA (2016) Whole organism transcriptome analysis of zebrafish models of Bardet-Biedl syndrome and Alstrom syndrome provides mechanistic insight into shared and divergent phenotypes. BMC Genomics 17:318
Butler MG, Wang K, Marshall JD, Naggert JK, Rethmeyer JA, Gunewardena SS, Manzardo AM (2015) Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alstrom syndromes. Adv Genomics Genet 2015:53–75
Moritz OL, Tam BM, Hurd LL, Peranen J, Deretic D, Papermaster DS (2001) Mutant rab8 impairs docking and fusion of rhodopsin-bearing post-Golgi membranes and causes cell death of transgenic Xenopus rods. Mol Biol Cell 12:2341–2351
Wang J, Deretic D (2013) Molecular complexes that direct rhodopsin transport to primary cilia. Prog Retin Eye Res 38:1–19
Gerdes JM, Christou-Savina S, Xiong Y, Moede T, Moruzzi N, Karlsson-Edlund P, Leibiger B, Leibiger IB, Ostenson CG, Beales PL, Berggren PO (2014) Ciliary dysfunction impairs beta-cell insulin secretion and promotes development of type 2 diabetes in rodents. Nat Commun 5:5308
Bettini V, Maffei P, Pagano C, Romano S, Milan G, Favaretto F, Marshall JD, Paisey R, Scolari F, Greggio NA, Tosetto I, Naggert JK, Sicolo N, Vettor R (2012) The progression from obesity to type 2 diabetes in Alström syndrome. Pediatr Diabetes 13:59–67
Spassky N, Meunier A (2017) The development and functions of multiciliated epithelia. Nat Rev Mol Cell Biol 18:423–436
Grimes DT, Boswell CW, Morante NF, Henkelman RM, Burdine RD, Ciruna B (2016) Zebrafish models of idiopathic scoliosis link cerebrospinal fluid flow defects to spine curvature. Science 352:1341–1344
Xiao Y, Leach J, Wang J, Martin JF (2016) Hippo/yap signaling in cardiac development and regeneration. Curr Treat Options Cardiovasc Med 18(38)
Zebrowski DC, Vergarajauregui S, Wu C-C, Piatkowski T, Becker R, Leone M, Hirth S, Ricciardi F, Falk N, Giessl A, Just S, Braun T, Weidinger G, Engel FB (2015) Developmental alterations in centrosome integrity contribute to the post-mitotic state of mammalian cardiomyocytes. Elife 4:e05563
Seeley ES, Nachury MV (2010) The perennial organelle: assembly and disassembly of the primary cilium. J Cell Sci 123:511–518
Ichihara S, Yamamoto K, Asano H, Nakatochi M, Sukegawa M, Ichihara G, Izawa H, Hirashiki A, Takatsu F, Umeda H, Iwase M, Inagaki H, Hirayama H, Sone T, Nishigaki K, Minatoguchi S, Cho M-C, Jang Y, Kim H-S, Park JE, Tada-Oikawa S, Kitajima H, Matsubara T, Sunagawa K, Shimokawa H, Kimura A, Lee J-Y, Murohara T, Inoue I, Yokota M (2013) Identification of a glutamic acid repeat polymorphism of ALMS1 as a novel genetic risk marker for early-onset myocardial infarction by genome-wide linkage analysis. Circulation 6:569–578
Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence logo generator. Genome Res 14:1188–1190
Kim K, Lee S, Chang J, Rhee K (2008) A novel function of CEP135 as a platform protein of C-NAP1 for its centriolar localization. Exp Cell Res 314:3692–3700
Jaykumar AB, Caceres PS, King-Medina KN, Liao TD, Datta I, Maskey D, Naggert JK, Mendez M, Beierwaltes WH, Ortiz PA (2018) Role of Alström syndrome 1 in the regulation of blood pressure and renal function. JCI Insight 3:e95076
I would like to thank the individuals with Alstrӧm syndrome, and their families, for supporting and participating in research.
Human tissue was obtained with local research ethics committee permission and written informed consent.
Conflict of interest
The author declares that there is no conflict of interest.
About this article
Cite this article
Hearn, T. ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits. J Mol Med 97, 1–17 (2019). https://doi.org/10.1007/s00109-018-1714-x
- ALMS motif
- Bardet-Biedl syndrome
- CART complex
- Endosomal recycling
- Insulin resistance
- Mitogenic cardiomyopathy